Horneff, Gerd
Borchert, Julia
Heinrich, Ria
Kock, Simon
Klaus, Pascal
Dally, Heike
Hagemann, Christine
Diesing, Joanna
Schönfelder, Tonio https://orcid.org/0000-0001-6158-4191
Funding for this research was provided by:
Pfizer Pharmaceuticals
Article History
Received: 10 August 2022
Accepted: 26 October 2022
First Online: 16 November 2022
Declarations
:
: Not applicable. Data in the databases are from healthcare claims, collected according to the 10th chapter of book V of social code in Germany (SGB V, Sozialgesetzbuch), and provided in anonymous form, solely for research purposes. Only WIG2 and InGef employees were granted access to the data, and only aggregated results were generated and presented.
: All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.
: All authors had complete autonomy for the process of designing the study, carrying out the analyses, interpreting the results and writing the manuscript. PK, CH, HD are employees of Pfizer Pharma GmbH. JB, RH, JD and TS are all employees of WIG2 GmbH, which is an independent institute and paid consultant to Pfizer Pharma GmbH for designing the study, carrying out the analyses, interpreting the results and writing the manuscript. GH received an honorarium from Pfizer Pharma GmbH in connection with designing the study and interpreting the results.